✦ LIBER ✦

Re: Thioridazine: Re-evaluating the Risk/Benefit Equation

✍ Scribed by Anna M. Timell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thioridazine: Re-evaluating the Risk/Ben

✍ Anna M. Timell 📂 Article 📅 2000 🏛 American Academy of Clinical Psychiatrists 🌐 English ⚖ 53 KB

Re-evaluating the potential of pharmacog

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Re-evaluating endoscopy-associated infec

✍ Ofstead, Cori L.; Dirlam Langlay, Alexandra M.; Mueller, Natalie J.; Tosh, Priti 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 145 KB

209 Re-evaluating the benefit of adjuvan

✍ T. Pickles; W. Kwan; M. Reed; P. Blood 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Evaluating the risk of patient re-identi

✍ El Emam, Khaled; Dankar, Fida K; Neisa, Angelica; Jonker, Elizabeth 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 435 KB

Nursing and midwifery: Re-evaluating the

✍ Joan Cameron; Julie Taylor 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 91 KB